These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2903346)

  • 1. Ganciclovir for severe cytomegalovirus infection in transplant recipients.
    Rostoker G; Ben Maadi A; Buisson C; Deforge L; Weil B; Lang P
    Lancet; 1988 Nov; 2(8620):1137-8. PubMed ID: 2903346
    [No Abstract]   [Full Text] [Related]  

  • 2. Ganciclovir for severe cytomegalovirus infection in transplant recipients.
    Nicholson ML; Flower AJ; Simpson A; Donnelly PK; Veitch PS; Bell PR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1501-2. PubMed ID: 2904627
    [No Abstract]   [Full Text] [Related]  

  • 3. DHPG treatment of kidney transplant recipients with severe CMV infection.
    Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
    Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
    Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
    [No Abstract]   [Full Text] [Related]  

  • 5. Ganciclovir for cytomegalovirus infection in renal transplant recipients.
    Lancet; 1989 Jan; 1(8631):216-7. PubMed ID: 2563118
    [No Abstract]   [Full Text] [Related]  

  • 6. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
    Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
    J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
    [No Abstract]   [Full Text] [Related]  

  • 7. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract]   [Full Text] [Related]  

  • 8. Life-threatening cytomegalovirus infection treated with dihydropropoxymethylguanine.
    Creasy TS; Flower AJ; Veitch PS
    Lancet; 1986 Mar; 1(8482):675. PubMed ID: 2869359
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
    Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
    [No Abstract]   [Full Text] [Related]  

  • 11. Ganciclovir treatment of cytomegalovirus disease in immunocompromised children.
    Gudnason T; Belani KK; Balfour HH
    Pediatr Infect Dis J; 1989 Jul; 8(7):436-40. PubMed ID: 2547191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir for treatment of cytomegalovirus disease.
    Jordan MC
    DICP; 1989 Jan; 23(1):85-6. PubMed ID: 2541567
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
    [No Abstract]   [Full Text] [Related]  

  • 15. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
    Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients.
    Himmelmann-Jud B; Wüthrich RP; Weinreich T; Binswanger U
    Nephrol Dial Transplant; 1998 May; 13(5):1326-7. PubMed ID: 9623588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of disseminated cytomegalovirus infection with ganciclovir in a patient with acquired immunodeficiency syndrome].
    Niiya K; Hirose S; Miyoshi I
    Nihon Naika Gakkai Zasshi; 1989 May; 78(5):686-7. PubMed ID: 2549136
    [No Abstract]   [Full Text] [Related]  

  • 18. Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections?
    Whitley RJ
    Ann Intern Med; 1988 Mar; 108(3):452-4. PubMed ID: 2829680
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus pneumonia: the use of ganciclovir in marrow transplant recipients.
    Ettinger NA; Selby P; Powles R; Milliken S; Gallagher C; Jameson B; Tryhorn Y; Stern H
    J Antimicrob Chemother; 1989 Jul; 24(1):53-62. PubMed ID: 2550414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ganciclovir and infections caused by the cytomegalic inclusion virus].
    Roy C
    Med Clin (Barc); 1989 Feb; 92(6):220-2. PubMed ID: 2540386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.